| Laura Voss, DPT | |
|
5255 Longley Ln Ste 140, Reno, NV 89511-5201 | |
| (775) 823-5350 | |
| (775) 823-5354 |
| Full Name | Laura Voss |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 3 Years |
| Location | 5255 Longley Ln Ste 140, Reno, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366010639 | NPI | - | NPPES |
| 4538 | Other | NV | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 4538 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nevada Physical Therapy Inc | 2668476987 | 7 |
News Archive
Aquiline Group was retained as ZYTO Corp's (PINKSHEETS: ZYTC) new Investor Relations Firm as of August 10, 2009.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.
Academics at the University of Warwick have found that low functional connectivity of the lateral orbitofrontal cortex that is associated with the tendency to smoke is associated with increased impulsiveness - which may contribute to the tendency to smoke.
› Verified 4 days ago
| Entity Name | Nevada Physical Therapy Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306802533 PECOS PAC ID: 2668476987 Enrollment ID: O20060829000218 |
News Archive
Aquiline Group was retained as ZYTO Corp's (PINKSHEETS: ZYTC) new Investor Relations Firm as of August 10, 2009.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.
Academics at the University of Warwick have found that low functional connectivity of the lateral orbitofrontal cortex that is associated with the tendency to smoke is associated with increased impulsiveness - which may contribute to the tendency to smoke.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Voss, DPT 5255 Longley Ln Ste 140, Reno, NV 89511-5201 Ph: (775) 823-5350 | Laura Voss, DPT 5255 Longley Ln Ste 140, Reno, NV 89511-5201 Ph: (775) 823-5350 |
News Archive
Aquiline Group was retained as ZYTO Corp's (PINKSHEETS: ZYTC) new Investor Relations Firm as of August 10, 2009.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.
Academics at the University of Warwick have found that low functional connectivity of the lateral orbitofrontal cortex that is associated with the tendency to smoke is associated with increased impulsiveness - which may contribute to the tendency to smoke.
› Verified 4 days ago
Kristen Anne Smith, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1664 N Virginia St, Reno, NV 89557 Phone: 775-327-2182 | |
Mrs. Teresa May Morros, CBIS Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1325 Airmotive Way, #175r, Reno, NV 89502 Phone: 775-473-1077 | |
Nicholas Patrick Gut, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1495 Mill St, Reno, NV 89502 Phone: 775-982-5000 Fax: 775-982-8100 | |
Jesson Baumgartner, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 343 Elm St Ste 202, Reno, NV 89503 Phone: 775-870-1480 Fax: 877-764-6351 | |
Dr. Stephen Brown, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1540 Fescue Ct, Reno, NV 89509 Phone: 775-391-7780 | |
Mr. George Mars, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 645 Sierra Rose #202, Reno, NV 89511 Phone: 775-825-9990 Fax: 775-827-1161 | |
Dr. Edwin Gary Starr, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 403 Hill St Ste 2, Reno, NV 89501 Phone: 775-544-6401 |